Marcus Vinícius Alves-Silva Selected Research

N-Glycosyl Hydrolases

1/2019	The F1F3 Recombinant Chimera of Leishmania donovani-Nucleoside Hydrolase (NH36) and Its Epitopes Induce Cross-Protection Against Leishmania (V.) braziliensis Infection in Mice.
1/2017	A Chimera Containing CD4+ and CD8+ T-Cell Epitopes of the Leishmania donovani Nucleoside Hydrolase (NH36) Optimizes Cross-Protection against Leishmania amazonesis Infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marcus Vinícius Alves-Silva Research Topics

Disease

4	Infections 01/2019 - 01/2014
1	Cutaneous Leishmaniasis 01/2017
1	Visceral Leishmaniasis (Kala Azar) 12/2015
1	Leishmaniasis 01/2014

Drug/Important Bio-Agent (IBA)

2	N-Glycosyl HydrolasesIBA 01/2019 - 01/2017
1	Immunoglobulin G (IgG)IBA 01/2019
1	EpitopesIBA 01/2019
1	Immunoglobulin A (IgA)IBA 01/2019
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2017
1	VaccinesIBA 01/2017
1	Meglumine AntimoniateIBA 12/2015
1	Pharmaceutical PreparationsIBA 12/2015
1	Combined VaccinesIBA 01/2014

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 12/2015
1	Therapeutics 12/2015